Join the Thrombocytopenia group to help and get support from people like you.
Thrombocytopenia News
Nplate (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
THOUSAND OAKS, Calif., Oct. 18, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (s...
FDA Approves Nplate (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia
THOUSAND OAKS, Calif., Dec. 14, 2018 /PRNewswire/ – Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for...
FDA Approves Mulpleta (lusutrombopag) for Thrombocytopenia in Adults with Chronic Liver Disease
On July 31, 2018, the Food and Drug Administration approved lusutrombopag (Mulpleta, Shionogi Inc.) for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or...
FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure
May 21, 2018 – The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are...
FDA Approves New Indication for Promacta (eltrombopag)
LONDON, Nov. 19, 2012 – GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Promacta for the treatment of thrombocytopenia (low blood platelet counts)...
Further information
Related condition support groups
Idiopathic (Immune) Thrombocytopenic Purpura, Bleeding Disorder